Inhibition of Inflammation Mediated Through the Tumor Necrosis Factor α Biochemical Pathway Can Lead to Favorable Outcomes in Alzheimer Disease.
about
Iridoids and Other Monoterpenes in the Alzheimer's Brain: Recent Development and Future Prospects.RIPK1 promotes inflammation and β-amyloid accumulation in Alzheimer's disease.Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines.Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer's and Vascular Dementia Drugs.In vivo neutralization of the protagonist role of macrophages during the chronic inflammatory stage of Huntington's diseaseMitogen-activated protein kinase phosphatase 1 protects PC12 cells from amyloid beta-induced neurotoxicity
P2860
Inhibition of Inflammation Mediated Through the Tumor Necrosis Factor α Biochemical Pathway Can Lead to Favorable Outcomes in Alzheimer Disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Inhibition of Inflammation Med ...... Outcomes in Alzheimer Disease.
@en
type
label
Inhibition of Inflammation Med ...... Outcomes in Alzheimer Disease.
@en
prefLabel
Inhibition of Inflammation Med ...... Outcomes in Alzheimer Disease.
@en
P2860
P356
P1476
Inhibition of Inflammation Med ...... Outcomes in Alzheimer Disease.
@en
P2093
Daniah Shamim
Michael Laskowski
P2860
P304
1179573517722512
P356
10.1177/1179573517722512
P577
2017-07-28T00:00:00Z